Clinical Trial: MDMA-AT for PTSD in Young Adults With Childhood Trauma

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07765693) titled 'MDMA-AT for PTSD in Young Adults With Childhood Trauma' on Aug. 11.

Brief Summary: This study is testing a new, emerging treatment for young adults (ages 18-26) with Posttraumatic Stress Disorder (PTSD). The treatment is combining the substance, MDMA, with up to three psychotherapy sessions, also known as MDMA-Assisted Therapy (MDMA-AT).

The main questions it aims to answer are:

* Is the treatment safe and feasible to administer?

* Does the treatment improve PTSD symptoms?

Participants will be asked to:

* Complete screening procedures, including a medical and psychiatric evaluation to ensure safe participation

* Attend up to t...